Evidence map›Paper›PMID 36465337›Full record

ArticleFrontiers in oncology2022

Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.

Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, Lisa Joseph, Maroie Barkati, Alejandro Berlin, Guila Delouya, Daniel Taussky, Marie-Claude Beauchemin, Benedicte Nicolas and 8 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Cynthia MénardRadiation Oncology, Centre Hospitaliser de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Inmaculada Navarro-DomenechPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Zhihu Amy LiuPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Lisa JosephPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Maroie BarkatiRadiation Oncology, Centre Hospitaliser de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Alejandro BerlinPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Guila DelouyaRadiation Oncology, Centre Hospitaliser de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Daniel TausskyRadiation Oncology, Centre Hospitaliser de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Marie-Claude BeaucheminRadiation Oncology, Centre Hospitaliser de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Benedicte NicolasRadiation Oncology, Centre Hospitaliser de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Samuel KadouryRadiation Oncology, Polytechnique Montreal, Montreal, QC, Canada.
Alexandra RinkPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Srinivas RamanPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Aravindhan SundaramurthyPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Robert WeersinkPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Dominic Beliveau-NadeauRadiation Oncology, Centre Hospitaliser de l'Université de Montréal (CHUM), Montreal, QC, Canada.
Joelle HelouPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Peter ChungPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Centre Hospitalier de l’Université de Montréal · CAUniversity of Toronto · CAPrincess Margaret Cancer Centre · CAPolytechnique Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.971344.].

Indexed as

brachytherapymagnetic resonance imagingprostate cancerradiotherapysalvage

Identifiers

PMID36465337
PMCPMC9714600
OpenAlexW4309265935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.